Two-, 5- and 10-year person-based prevalence of cancer as of end of follow-up (Nov. 1, 2020)
| Variable | No. of people diagnosed with cancer | Prevalence, % (95% CI) |
|---|---|---|
| 2-year prevalence (cancers diagnosed since 2018) | ||
| All cancers | 139 | 0.8 (0.7–0.9) |
| Infection-unrelated cancer | 91 | 0.5 (0.4–0.6) |
| Infection-related cancer | 48 | 0.3 (0.2–0.4) |
| Infection-related NADC | 26 | 0.2 (0.1–0.2) |
| ADC | 22 | 0.1 (0.1–0.2) |
| 5-year prevalence (cancers diagnosed since 2015) | ||
| All cancers | 313 | 1.8 (1.6–2.0) |
| Infection-unrelated cancer | 197 | 1.2 (1.0–1.3) |
| Infection-related cancer | 116 | 0.7 (0.5–0.8) |
| Infection-related NADC | 60 | 0.3 (0.3–0.4) |
| ADC | 56 | 0.3 (0.2–0.4) |
| 10-year prevalence (cancers diagnosed since 2010) | ||
| All cancers | 510 | 3.0 (2.7–3.2) |
| Infection-unrelated cancer | 289 | 1.7 (1.5–1.9) |
| Infection-related cancer | 221 | 1.3 (1.1–1.5) |
| Infection-related NADC | 103 | 0.6 (0.5–0.7) |
| ADC | 118 | 0.7 (0.6–0.8) |
Note: ADC = AIDS-defining cancer, CI = confidence interval, NADC = non-AIDS defining cancer.